Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Palatin Technologies (0KF3) Price & Analysis

0KF3 Stock Chart & Stats

$5.38$0.68(14.47%)
At close: 4:00 PM EDT
$5$7.5$10$12.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$5.00 - $5.38
52-Week Range
$4.60 - $27.71
Previous Close
$4.70
Volume
1
Average Volume (3M)
18
Market Cap
$8.90M
Enterprise Value
$35.04M
Total Cash (Recent Filing)
$7.49M
Total Debt (Recent Filing)
$223.68K
Price to Earnings (P/E)
―
Beta
-0.57
Next Earnings
Nov 16, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

MC4R Pipeline Differentiation

The portfolio combines peptide and oral MC4R approaches aimed at rare obesity disorders, with preclinical efficacy and selectivity signals. If reproduced clinically, these attributes could support differentiated therapies and multiple development paths over the next several quarters.

Partnered Revenue And Milestone Potential

Partnered programs are already generating revenue and provide potential milestone and royalty streams beyond Vyleesi. The Boehringer agreement also includes substantial success-based milestones, creating a durable external validation and funding avenue if programs progress.

Improving Loss And Cash-use Trend

Lower net losses and reduced operating cash use represent measurable improvement from fiscal 2025, helped by collaboration revenue. Although profitability has not been reached, this trend could extend financial runway and improve capital efficiency if revenue support continues.

Bears Say

Going-concern Funding Risk

Insufficient cash relative to planned operations creates a structural financing dependency, with development milestones explicitly subject to funding. New equity or other capital may be unavailable or costly, potentially delaying programs and weakening shareholder economics.

Persistent Losses And Cash Burn

The company has not demonstrated self-funding operations despite narrower losses and lower cash use. Continued negative cash generation can consume financing proceeds, limit investment in the pipeline, and leave the business exposed if external capital or partner receipts are delayed.

Clinical Tolerability And Development Hurdles

Known nausea, vomiting, hyperpigmentation and a prior oral-program toxicity issue create meaningful barriers to durable product adoption. These risks may require additional analogue optimization, safety testing and development spending before clinical differentiation is established.

Palatin Technologies News

0KF3 FAQ

What was Palatin Technologies’s price range in the past 12 months?
Palatin Technologies lowest share price was $4.60 and its highest was $27.71 in the past 12 months.
What is Palatin Technologies’s market cap?
Palatin Technologies’s market cap is $8.90M.
When is Palatin Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Palatin Technologies’s earnings last quarter?
Palatin Technologies released its earnings results on Sep 28, 2026. The company reported -$1.11 earnings per share for the quarter, beating the consensus estimate of -$1.2 by $0.09.
Is Palatin Technologies overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Palatin Technologies pay dividends?
Palatin Technologies pays a Notavailable dividend of $0.285 which represents an annual dividend yield of ―. See more information on Palatin Technologies dividends here
What is Palatin Technologies’s EPS estimate?
Palatin Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Palatin Technologies have?
Palatin Technologies has 1,780,939 shares outstanding.
What happened to Palatin Technologies’s price movement after its last earnings report?
Palatin Technologies reported an EPS of -$1.11 in its last earnings report, beating expectations of -$1.2. Following the earnings report the stock price went down -0.75%.
Which hedge fund is a major shareholder of Palatin Technologies?
Currently, no hedge funds are holding shares in GB:0KF3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology